Compostella Leonida, Lakusic Nenad, Compostella Caterina, Truong Li Van Stella, Iliceto Sabino, Bellotto Fabio
Leonida Compostella, Li Van Stella Truong, Fabio Bellotto, Preventive Cardiology and Rehabilitation, Istituto Codivilla-Putti, I-32043 Cortina d'Ampezzo (BL), Italy.
World J Cardiol. 2017 Jan 26;9(1):27-38. doi: 10.4330/wjc.v9.i1.27.
To assess the prevalence of depressed heart rate variability (HRV) after an acute myocardial infarction (MI), and to evaluate its prognostic significance in the present era of immediate reperfusion.
Time-domain HRV (obtained from 24-h Holter recordings) was assessed in 326 patients (63.5 ± 12.1 years old; 80% males), two weeks after a complicated MI treated by early reperfusion: 208 ST-elevation myocardial infarction (STEMI) patients (in which reperfusion was successfully obtained within 6 h of symptoms in 94% of cases) and 118 non-ST-elevation myocardial infarction (NSTEMI) patients (percutaneous coronary intervention was performed within 24 h and successful in 73% of cases). Follow-up of the patients was performed telephone interviews a median of 25 mo after the index event (95%CI of the mean 23.3-28.0). Primary end-point was occurrence of all-cause or cardiac death; secondary end-point was occurrence of major clinical events (MCE, defined as mortality or readmission for new MI, new revascularization, episodes of heart failure or stroke). Possible correlations between HRV parameters (mainly the standard deviation of all normal RR intervals, SDNN), clinical features (age, sex, type of MI, history of diabetes, left ventricle ejection fraction), angiographic characteristics (number of coronary arteries with critical stenoses, success and completeness of revascularization) and long-term outcomes were analysed.
Markedly depressed HRV parameters were present in a relatively small percentage of patients: SDNN < 70 ms was found in 16% and SDNN < 50 ms in 4% of cases. No significant differences were present between STEMI and NSTEMI cases as regards to their distribution among quartiles of SDNN ( =1.536, = 0.674). Female sex and history of diabetes maintained a significant correlation with lower values of SDNN at multivariate Cox regression analysis (respectively: = 0.008 and = 0.008), while no correlation was found between depressed SDNN and history of previous MI ( = 0.999) or number of diseased coronary arteries ( = 0.428) or unsuccessful percutaneous coronary intervention (PCI) ( = 0.691). Patients with left ventricle ejection fraction (LVEF) < 40% presented more often SDNN values in the lowest quartile ( < 0.001). After > 2 years from infarction, a total of 10 patients (3.1%) were lost to follow-up. Overall incidence of MCE at follow-up was similar between STEMI and NSTEMI ( = 0.141), although all-cause and cardiac mortality were higher among NSTEMI cases (respectively: 14% 2%, = 0.001; and 10% 1.5%, = 0.001). The Kaplan-Meier survival curves for all-cause mortality and for cardiac deaths did not reveal significant differences between patients with SDNN in the lowest quartile and other quartiles of SDNN (respectively: = 0.137 and = 0.527). Also the MCE-free survival curves were similar between the group of patients with SDNN in the lowest quartile the patients of the other SDNN quartiles ( = 0.540), with no difference for STEMI ( = 0.180) or NSTEMI patients ( = 0.541). By the contrary, events-free survival was worse if patients presented with LVEF < 40% ( = 0.001).
In our group of patients with a recent complicated MI, abnormal autonomic parameters have been found with a prevalence that was similar for STEMI and NSTEMI cases, and substantially unchanged in comparison to what reported in the pre-primary-PCI era. Long-term outcomes did not correlate with level of depression of HRV parameters recorded in the subacute phase of the disease, both in STEMI and in NSTEMI patients. These results support lack of prognostic significance of traditional HRV parameters when immediate coronary reperfusion is utilised.
评估急性心肌梗死(MI)后心率变异性(HRV)降低的发生率,并在当前直接再灌注时代评估其预后意义。
对326例患者(年龄63.5±12.1岁;80%为男性)进行了时域HRV评估(通过24小时动态心电图记录获得),这些患者在早期再灌注治疗的复杂性MI发生两周后:208例ST段抬高型心肌梗死(STEMI)患者(其中94%的病例在症状出现后6小时内成功实现再灌注)和118例非ST段抬高型心肌梗死(NSTEMI)患者(在24小时内进行了经皮冠状动脉介入治疗,73%的病例成功)。在索引事件发生后中位25个月(平均的95%CI为23.3 - 28.0)通过电话访谈对患者进行随访。主要终点是全因死亡或心源性死亡的发生;次要终点是主要临床事件(MCE,定义为死亡或因新发MI、新的血管重建、心力衰竭发作或中风再次入院)的发生。分析了HRV参数(主要是所有正常RR间期的标准差,SDNN)、临床特征(年龄、性别、MI类型、糖尿病史、左心室射血分数)、血管造影特征(有严重狭窄的冠状动脉数量、血管重建的成功和完整性)与长期结局之间可能的相关性。
HRV参数明显降低的患者比例相对较小:16%的病例SDNN < 70 ms,4%的病例SDNN < 50 ms。STEMI和NSTEMI病例在SDNN四分位数分布方面无显著差异( =1.536, = 0.674)。在多变量Cox回归分析中,女性和糖尿病史与较低的SDNN值保持显著相关性(分别为: = 0.008和 = 0.008),而SDNN降低与既往MI史( = 0.999)、病变冠状动脉数量( = 0.428)或经皮冠状动脉介入治疗(PCI)不成功( = 0.691)之间未发现相关性。左心室射血分数(LVEF)< 40%的患者更常出现SDNN值处于最低四分位数( < 0.001)。梗死> 2年后,共有10例患者(3.1%)失访。随访时MCE的总体发生率在STEMI和NSTEMI之间相似( = 0.141),尽管NSTEMI病例中的全因死亡率和心源性死亡率更高(分别为:14% 2%, = 0.001;和10% 1.5%, = 0.001)。全因死亡率和心源性死亡的Kaplan-Meier生存曲线在SDNN处于最低四分位数的患者与SDNN其他四分位数的患者之间未显示出显著差异(分别为: = 0.137和 = 0.527)。SDNN处于最低四分位数的患者组与其他SDNN四分位数的患者组之间的无MCE生存曲线也相似( = 0.540),STEMI患者( = 0.180)或NSTEMI患者( = 0.541)无差异。相反,如果患者LVEF < 40%,无事件生存情况更差( = 0.001)。
在我们近期发生复杂性MI的患者组中,发现自主神经参数异常,STEMI和NSTEMI病例的发生率相似,与初级PCI时代之前报道的情况相比基本未变。在STEMI和NSTEMI患者中,疾病亚急性期记录的HRV参数降低水平与长期结局无关。这些结果支持在采用直接冠状动脉再灌注时传统HRV参数缺乏预后意义。